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Abstract
Background One factor related to disability in people with spinal deformity is decreased postural control and increased risk of 
falling. However, little is known about the effect of osteoporotic vertebral compression fractures (OVCFs) and their recovery 
on gait and stability. Walking characteristics of older adults with and without vertebral fractures have not yet been compared.
Aims The purpose of the current study was to examine the spatiotemporal gait parameters and their variability in patients 
with an OVCF and healthy participants during treadmill walking at baseline and after 6 months of recovery.
Methods Twelve female patients suffering a symptomatic OVCF were compared to 11 matched controls. Gait analysis was 
performed with a dual-belt instrumented treadmill with a 180° projection screen providing a virtual environment (computer-
assisted rehabilitation environment). Results of patients with an OVCF and healthy participants were compared. Furthermore, 
spatiotemporal gait parameters were assessed over 6 months following the fracture.
Results Patients suffering from an OVCF appeared to walk with significantly shorter, faster and wider strides compared to 
their healthy counterparts. Although stride time and length improved over time, the majority of the parameters analysed 
remained unchanged after 6 months of conservative treatment.
Discussion Since patients do not fully recover to their previous level of mobility after 6 months of conservative treatment 
for OVCF, it appears of high clinical importance to add balance and gait training to the treatment algorithm of OVCFs.
Conclusions Patients suffering from an OVCF walk with shorter, faster and wider strides compared to their healthy coun-
terparts adopt a less stable body configuration in the anterior direction, potentially increasing their risk of forward falls if 
perturbed. Although stride time and stride length improve over time even reaching healthy levels again, patients significantly 
deviate from normal gait patterns (e.g. in stability and step width) after 6 months of conservative treatment.
Keywords Spatiotemporal gait parameters · OVCF · Gait analysis · Vertebral fracture · Ageing spine
Introduction
One of the most common fractures among older adults 
is osteoporotic vertebral compression fractures (OVCFs), 
with an estimated 500,000 new fractures occurring every 
year in Europe [1, 2]. After an OVCF, there is dispro-
portionate height loss from the anterior vertebral body 
resulting in a wedge-shaped vertebra [3]. The presence 
of an OVCF is a strong predictor for subsequent vertebral 
fractures [4]. Wedge accumulation over multiple thora-
columbar levels may lead to thoracolumbar hyperkypho-
sis. Subsequent sagittal malalignment with inability to 
stand upright is the strongest driver of pain and disability 
in older adults suffering from spinal deformity [5, 6]. In 
the majority of the patients the initial pain caused by the 
fracture usually subsides within a couple of weeks, with 
Eva Jacobs and Christopher McCrum contributed equally.
Electronic supplementary material The online version of this 
article (https ://doi.org/10.1007/s4052 0-019-01203 -9) contains 
supplementary material, which is available to authorized users.
 * Eva Jacobs 
 e.jacobs@maastrichtuniversity.nl
1 Department of Orthopaedic Surgery, Research School 
CAPHRI, Maastricht University Medical Center, P. 
Debyelaan 25, 6229 HX Maastricht, The Netherlands
2 Department of Nutrition and Movement Sciences, 
NUTRIM School of Nutrition and Translational Research 
in Metabolism, Maastricht University Medical Center, 
Maastricht, The Netherlands
3 Institute of Movement and Sport Gerontology, German Sport 
University, Cologne, Germany
240 Aging Clinical and Experimental Research (2020) 32:239–246
1 3
healing of the fracture [2]. However, up to one-third of 
patients experience incapacitating pain for months to years 
due to insufficient response to treatment [2, 7].
One factor related to disability in people with spi-
nal deformity such as thoracolumbar hyperkyphosis is 
decreased postural control and an increased risk of fall-
ing [8, 9]. Falls among older adults, especially those with 
osteoporosis, are associated with high morbidity, even 
mortality and involve high costs for society [8–10]. De 
Groot et al. [8] described that patients with an OVCF and 
thoracolumbar hyperkyphosis demonstrate impaired pos-
tural control. This may be due to the fact that in thora-
columbar hyperkyphosis, there is an increased forward 
bending moment due to the forward curvature of the trunk, 
which shifts the body’s centre of mass forward relative to 
the centre of rotation, i.e. the spine. In this situation, it 
may be more difficult to keep the centre of mass within 
the base of support (a requirement for stability in static 
situations) [11]. However, as the majority of falls in older 
adults occurs during walking, stability control specifically 
while walking should be considered. It is important to note 
that stability control during static tasks shows little rela-
tionship with more dynamic and reactive tasks [12–14]. 
In dynamic situations such as walking, the velocity of 
the centre of mass must be accounted for when assessing 
stability [11, 15]. For this purpose, Hof et al. [11] pro-
posed the extrapolated centre of mass concept, in which 
the position and velocity of the centre of mass are taken 
into account when determining the stability of the body 
position. As people with thoracolumbar hyperkyphosis 
already have a more anterior centre of mass, stability in 
the anterior direction during walking may be reduced, per-
haps increasing the difficulty in coping with forward losses 
of balance (e.g. trips) [8, 9]. Gait variability is another 
quantifiable feature of walking that is altered in clinically 
relevant syndromes or symptoms, such as falling, frailty 
and neuro-degenerative diseases. In literature, it has been 
demonstrated that increased gait variability is associated 
with an increased risk of falling [16]. However, there is 
little information available on the effect of OVCF on gait 
stability and variability.
The current study aimed to examine the spatiotempo-
ral gait parameters and their variability in patients with an 
OVCF and healthy participants during treadmill walking. 
Furthermore, this study aimed to monitor recovery of spa-
tiotemporal gait parameters and variability in patients suf-
fering an OVCF over 6 months following the fracture. It 
was hypothesized that gait would be more variable in peo-
ple with an osteoporotic vertebral fracture and that stability 
in the anterior direction would be reduced compared with 
healthy participants. Regarding the longitudinal data, it was 




Twelve female patients [mean age 68 (55–78) years, mean 
height 1.61 m (1.51–1.73 m), weight 67.34 kg (49–88 kg)] 
with a symptomatic OVCF who presented at the emer-
gency department of the Maastricht University Medical 
Centre gave a written informed consent to participate in 
this study. Participants were included if they were female, 
aged 55 years or older and were fully ambulatory (able 
to perform a 15-m walk test without assistance). Patients 
were excluded if the vertebral fracture was unstable and 
required surgery, if they had neurological deficits, active/
recent cancer, a psychiatric diagnosis, a history of neu-
rogenic or myopathic disorders impairing sensory or 
motor function or medication that could affect balance 
or walking. The study was explained before obtaining 
informed consent and conducted in accordance with the 
Declaration of Helsinki and was approved by the Maas-
tricht University Medical Centre medical ethics com-
mittee (NL52978.057.15). Patients were treated with an 
orthosis  (Osteolind® plus, Werkmeister, Wanfried, Ger-
many) which they wore all day for the first 6 weeks. From 
6 weeks to 6 months, wearing the orthosis was optional. 
Data were collected at baseline, after 6 weeks and after 
6 months.
A control group with gender, age, height and weight 
matched, was selected from the database of a previ-
ous study in the Maastricht University Medical Centre 
(NL58205.068.16) with 11 healthy older female adults 
[71 years (66–78 years), 1.64 m height (1.58–1.70 m) 
and 68.5 kg (62–81 kg) weight]. The participants had no 
self-reported history of walking difficulties, dizziness or 
balance problems, could walk for at least 30 min without 
assistance, without stopping and had no known neuromus-
cular condition, injury or medication that could affect bal-
ance or walking. Unpaired t tests confirmed that the groups 
were not significantly different in age, height or weight. 
Additionally, equivalence tests with 90% confidence inter-
vals revealed that the group differences were statistically 
equivalent and not meaningfully different.
Equipment
The measurements were conducted with the computer-
assisted rehabilitation environment extended (CAREN; 
Motekforce Link, Amsterdam, The Netherlands), includ-
ing a dual-belt instrumented treadmill (force plates: 
1000 Hz), a 12-camera Vicon Nexus motion capture sys-
tem (100 Hz; Vicon Motion Systems, Oxford, UK) and a 
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virtual environment that provided optic flow. Participants 
wore a safety harness connected to an overhead frame. 
Ten retroreflective markers were attached to anatomical 
landmarks (one acromion marker on each side, four pelvic 
markers, one marker each lateral distal femur condyle and 
one marker on each lateral malleolus) and were tracked 
by the motion capture system. The marker trajectories 
were filtered using a low-pass second-order Butterworth 
filter (zero phase) with a cut-off frequency of 12 Hz. Foot 
touchdown and toe-off were determined using the tread-
mill force plates (50-N threshold) in combination with a 
marker-based method [17].
Measurement procedure
Participants first completed treadmill walking familiarisa-
tion trials (consisting of 90-s walking at 1 m/s followed by 
90-s walking at self-paced speed) after which they contin-
ued walking for 3 min at a self-paced mode followed by 
3 min at a set speed of 1.0 m/s. For each of the 3 min, the 
first 90 s was unperturbed walking and the following 90 s 
included five mediolateral platform-shift perturbations. The 
perturbations were a part of another study and are not further 
discussed here. The final 60 strides of the 1-m/s walking 
trial were taken for further analysis, as well as the average 
walking speed during the unperturbed 90-s self-paced meas-
urement as a functional outcome. In the OVCF group, the 
change in pain level was assessed using an 11-point visual 
analogue scale (VAS) where level 10 implies extreme pain 
and level 0 no pain at all.
Healthy control data
Gait data from a walking trial at 1.0 m/s were taken for 
analysis. It is important to note that a slightly different 
reduced kinematic model was used for these subjects. For 
these participants, six markers were attached to each hal-
lux, each trochanter major, the sacrum and the C7 verte-
bra. To determine the likely absolute differences of the two 
marker sets, we conducted a small pilot study with six par-
ticipants wearing both marker sets. The protocol for these 
healthy pilot participants, and the details on the marker set 
comparability pilot study can be found in the supplement. 
The results section of the current study describes both the 
absolute data and the results accounting for the absolute 
differences found between the marker sets.
Spatiotemporal gait and variability parameters
The gait parameters considered were stride time, stride 
length, step width and double support time. The mean 
value for each participant was calculated from all recorded 
steps. Additionally, the coefficient of variation (CV) was 
calculated for all gait parameters to evaluate gait variabil-
ity. The margins of stability (MoS) were calculated in both 
the anteroposterior (AP) and mediolateral (ML) directions 
at foot touchdown as the AP or ML distance between the 
boundary of the base of support (BoS; the ankle marker) 
and the extrapolated centre of mass (XCoM), as defined by 
Hof et al. [11]. For the estimation of the centre of mass 
position and velocity, the average positions of the four pel-
vis markers were used. For the MoS the averages, medians 
and standard deviations were used for analysis.
Statistics
Independent t tests were used to determine if differences 
existed between healthy control participants and patients 
with OVCF in all outcome parameters. To detect poten-
tial changes in the gait parameters in the patients over 
time, one-way repeated measures ANOVAs with Tukey 
post hoc tests for multiple comparisons were conducted. 
Statistical analyses were conducted with GraphPad Prism 
version 7.03 for Windows (GraphPad Software Inc., La 
Jolla, California, USA). Significance was set at α = 0.05.
Table 1  Spatiotemporal characteristics and margins of stability during walking at 1 m/s
a This difference is higher than the upper confidence limit of the Bland–Altman plot, indicating that the OVCF group had a larger MoS AP value 
by on average 6 cm if the same marker set would have been used
* indicate p < 0.05
Stride time (s) Stride length (m) Step width (m) Double support 
time (s)
MoS AP (m) MoS ML (m)
OVCF 1.09 ± 0.05 1.10 ± 0.05 0.22 ± 0.03 0.13 ± 0.02 − 0.100 ± 0.034 0.048 ± 0.011
Control 1.17 ± 0.08 1.17 ± 0.08 0.14 ± 0.03 0.14 ± 0.02 0.105 ± 0.032 0.001 ± 0.009
p value 0.013* 0.024* < 0.0001* 0.256 < 0.0001* < 0.0001*
Exceeds bias of marker 
set difference?
Yes Yes Yes N/A Yesa Yes




The results for the spatiotemporal gait parameters at baseline 
(stride time, stride length, step width, double support time) 
of the OVCF group and the healthy controls are presented 
in Table 1. The independent t tests revealed a significantly 
shorter stride time, a significantly shorter stride length and 
a significantly greater step width for the OVCF group com-
pared to the healthy participants, with no significant dif-
ference in double support time (Table 1). Additionally, the 
independent t tests revealed significantly lower AP MoS and 
significantly higher ML MoS for the OVCF group compared 
to controls (Table 1). All of the above differences exceeded 
any bias due to the difference in marker sets (Table 1; Sup-
plementary Information). However, it is important to high-
light that when accounting for the difference in the marker 
sets, the AP MoS is estimated to be on average 6 cm greater 
for the OVCF group (i.e. more stable anteriorly). No sig-
nificant differences in the coefficients of variation for the 
four spatiotemporal gait parameters were found between the 
groups (Table 2). 
Longitudinal data
The repeated measures ANOVAs revealed significant effects 
of time on stride time (F[1.2,14] = 6.4, p = 0.0191; Fig. 1) 
and stride length (F[1.2,13] = 4.4, p = 0.0495; Fig. 1), and 
non-significant effects of time on step width (F[1.9,21] = 2.4, 
p = 0.1178; Fig.  1), double support time (F[1.6,17] = 1.7, 
p = 0.2182; Fig.  1), AP MoS (F[1.3,14] = 2.5, p = 0.1269; 
Fig. 2) and ML MoS (F[1.5,16] = 2.7, p = 0.1075; Fig. 2). 
For the significant effects, post hoc Tukey multiple com-
parisons tests revealed a significant difference between 
stride time (Fig. 1) at T0 vs. T2 (p = 0.0315) but no sig-
nificant difference between T0 and T1 (p = 0.1045) or T1 
and T2 (p = 0.4305). For stride length, no significant post 
hoc Tukey tests were found (p = 0.2779, p = 0.0751 and 
p = 0.0961 for T0 vs. T1, T0 vs. T2 and T1 vs. T2, respec-
tively; Fig. 1). No significant effects of time were found for 
variability in stride time (F[1.6,18] = 0.75, p = 0.4573), stride 
length (F[1.2,13] = 0.79, p = 0.4136), step width (F[1.5,17] = 3.3, 
p = 0.0742), double support time (F[1.8,20] = 1.1, p = 0.3606) 
(Fig. 1), AP MoS (F[1.8,20] = 0.14, p = 0.8522) or ML MoS 
(F[1.3,15] = 0.8, p = 0.4206) (Fig.  2). As two parameters 
showed significant improvements over time, the T2 val-
ues of stride time and length were statistically compared 
to the healthy control data using independent t tests, which 
revealed no significant differences for stride time (p = 0.397) 
and stride length (p = 0.550). Regarding the mean self-
selected walking speed from the 90-s period, there was 
a statistically significant effect of time on walking speed 
(F[1.6,18] = 8.1, p = 0.0046; medians of 1.095 m/s, 1.250 m/s 
and 1.260 m/s for T0, T1 and T2, respectively; Fig. 3), with 
post hoc Tukey tests revealing significantly faster walking 
speeds at T2 (p = 0.018) and T1 (p = 0.041) compared to 
T0, but not between T1 and T2 (p = 0.409). Compared to 
baseline, patients showed significantly decreased VAS-pain 
scores 6 weeks and 6 months after fracture indicating less 
pain (VAS pain 5.17 + 1.64, 1.83 + 1.47 and 1.83 + 1.53, 
respectively; p < 0.05). Remarkably, four patients with dis-
abling pain after 6 months of recovery showed no or little 
improvement in gait and stability over time, indicating that 
pain plays an important role in the recovery of gait after 
suffering an OVCF.
Discussion
The current study primarily aimed to determine differences 
in spatiotemporal gait parameters and their variability 
between patients with an OVCF and healthy age-, gender-, 
height- and weight-matched participants during treadmill 
walking. The second aim was to assess whether those param-
eters and their variability changed over 6 months following 
the fracture. In contrast to our first hypothesis, the patients 
suffering an OVCF did not demonstrate more variable gait 
compared to the healthy controls. However, patients with an 
OVCF did walk with shorter, faster and wider strides at the 
given speed of 1 m/s compared to the healthy controls. These 
differences in stride length and time were no longer present 
6 months after the fracture, indicating a return to a “healthy” 
stride time and length. Walking speed also improved after 
6 months of conservative treatment. However, step width 
and both AP and ML margins of stability did not recover 
over time.
Table 2  Variability in the spatiotemporal characteristics and margins of stability during walking at 1 m/s
Stride time (CV) Stride length (CV) Step width (CV) Double support 
time (CV)
MoS AP (SD) MoS ML (SD)
OVCF 2.09 ± 0.69 3.49 ± 2.47 11.87 ± 8.04 9.39 ± 3.22 0.019 ± 0.007 0.014 ± 0.004
Control 1.93 ± 0.62 2.90 ± 1.20 16.48 ± 5.48 10.49 ± 2.34 0.022 ± 0.007 0.013 ± 0.003
p value 0.556 0.480 0.126 0.361 0.331 0.754
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Fig. 1  Stride time, stride 
length, step width and double 
support time in patients with 
an OVCF at baseline (T0), after 
6 weeks (T1) and after 6 months 
(T2). Repeated measurements 
ANOVA demonstrated a sig-
nificant improvement over time 
for stride time and length. There 
was no significant improve-
ment in step width and double 
support time over time. Data 
presented for each patient, hori-
zontal bar represents median 
with 95% confidence intervals
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This is the first study in literature to elucidate the spati-
otemporal gait characteristics and their variability of older 
adults suffering an OVCF. Hence comparison with previ-
ous studies is limited. In the context of this investigation, 
patients suffering an OVCF demonstrated shorter, faster and 
wider strides than healthy age-matched controls. These dif-
ferences are also reported between young and older healthy 
adults, which may represent limitations in the ability to pro-
duce equivalent step lengths due to differences in muscle 
strength or physical capacity [18]. However, in the case of 
the current study, it might be speculated that the difference 
found in spatiotemporal gait parameters at baseline between 
the OVCF group and healthy controls might be due to pain. 
The differences in stride time and length at T0 and the lack 
of differences at T2 coincide with the healing of the frac-
ture and with a significant decrease in pain of the patients. 
Given that those four patients who still had disabling pain 
at 6 months also showed a lack of improvement in the gait 
parameters suggests that an association exists between pain 
and (recovery of) gait after suffering an OVCF. Venmans 
et al. [19] found that 60% of conservatively treated patients 
with acute OVCFs had sufficient pain relief and good func-
tional recovery within approximately 3 months after the 
acute fracture. However, 40% of patients still had disabling 
pain after 1 year [19, 20]. Especially, these patients should 
be screened for a history of falls or balance impairment and 
should follow appropriate (preventative) balance or gait 
training.
In a study by Hausdorff [16], stride time CV appeared to 
be a useful parameter to assess the risk of falling in elderly. 
In the current study, no significant difference in stride time 
CV was found between the OVCF group and healthy con-
trols. This is in accordance with the study of de Groot et al. 
[8], in which only patients with a flexed posture demon-
strated a greater variability in stride time in comparison 
with patients with a normal posture, whereas there were 
no differences between the groups in the presence of verte-
bral fractures. However, although there was no significant 
difference in stride time CV, in the current study vertebral 
fractures did seem to lead to alterations in AP and ML MoS, 
both with relatively greater stability than the control par-
ticipants (when accounting for the marker set differences). 
The increased ML MoS corresponds with the significantly 
wider steps observed in the OVCF group. A wide base of 
support during gait is typically indicative of poor or cautious 
dynamic balance control [21]. However, the shorter stride 
length but slightly increased AP MoS (when accounting for 
marker set differences) implies that it was not the change in 
base of support that affected the MoS (as the value would 
then be smaller in the patients), but rather that the centre of 
mass position and/or accelerations that were less anterior 
in the OVCF group. This may represent a compensation for 
pain or discomfort to reduce fluctuations in the upper body. 
The likelihood that the AP MoS difference is mainly due to 
the centre of mass characteristics is supported by the longi-
tudinal data, as despite an increased stride length over time 
(and, therefore, a larger base of support) these changes are 
not reflected in the AP MoS.
Fig. 2  Margins of stability in the anteroposterior and mediolateral 
direction in patients with an OVCF at baseline (T0), after 6  weeks 
(T1) and after 6  months (T2). Repeated measures ANOVA demon-
strated no significant differences over time. Data are presented for 
each patient; horizontal bar represents median with 95% confidence 
intervals
Fig. 3  Self-selected walking speed in patients with an OVCF at base-
line (T0), after 6 weeks (T1) and after 6 months (T2). There was a 
significant improvement over time. Data are presented for each 
patient; horizontal bar represents median with 95% confidence inter-
vals
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Gait is an important indicator of health and can be influ-
enced by many variables [16, 22–24]. Older adults with 
chronic low back pain exhibit significantly different gait 
patterns compared to age- and sex-matched adults with-
out chronic low back pain [25]. In the current study, it was 
demonstrated that only two of all measured gait parameters 
improved and returned to “healthy” levels after 6 months of 
conservative treatment (self-selected gait speed and stride 
time at 1 m/s). Most parameters, including step width, dou-
ble support time and MoS, remained unchanged (Fig. 1). 
These parameters are closely related to gait stability. There-
fore, it appears that overall, the capacity of the patients’ gait 
in terms of stride length and speed improved over time, but 
deficits in stability did not. This may imply that the OVCF 
population is at a greater risk for incident disability, such as 
falling, than their healthy counterparts even 6 months after 
conservative treatment [24]. These findings suggest that an 
OVCF can be the serious beginning of a downward cascade 
which should be taken into account in the multimodal treat-
ment of vertebral fractures and osteoporosis.
An important limitation of this study is the small number 
of subjects that were included, which may have affected the 
power of the study. However, as patients suffering an OVCF 
are often unable to participate due to incapacitating pain and 
inability to walk independently, together with the fact that 
these patients are typically characterised by a combination 
of physiological, psychological and social problems, gait 
and stability studies on this specific condition will always 
be faced with this challenge. However, the individual data 
points and the changes over time do appear to confirm the 
statistical outcomes and so we believe that this may not 
have affected the overall conclusions of the study. A second 
limitation is the lack of consistent marker sets in the patient 
and control groups. However, the pilot study with 360 data 
points in the Bland–Altman plots addressed this limitation 
providing sufficient data to estimate the absolute difference 
in the marker sets. Furthermore, the longitudinal analysis 
has not been affected by this limitation as the patients were 
measured every time with the same marker set.
In conclusion, the results of the current study indicated 
that patients suffering from an OVCF walk with shorter, 
faster and wider strides compared to their healthy counter-
parts adopt a less stable body configuration in the anterior 
direction, potentially increasing their risk of forward falls if 
perturbed. Although stride time and stride length improve 
over time even reaching healthy levels again, patients sig-
nificantly deviate from normal gait patterns (e.g. in stability 
and step width) after 6 months of conservative treatment.
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